#EHA2026 is a reminder of how much rides on T cell persistence in cell therapy. The gap is upstream — in manufacturing — knowing which populations are worth selecting before infusion. Functional co-culture with live recovery is how you build that evidence. That’s TROVO.

New #JITC article: "KLF4 overexpression in CAR T cells enhances antitumor potency by preventing exhaustion" jitc.bmj.com/content/14/5/e0…

Most T cell assays force a tradeoff: throughput or resolution. TROVO runs thousands of co-cultures on a single standard plate, tracks cytotoxicity and persistence in real time, and retrieves viable cells directly from culture. enrichbiosystems.com #CART #TIL #Biotech

Most T cell screens tell you what a cell is. TROVO tells you what it does, and then hands it to you alive. Joining the conversation here. #CART #TILtherapy #celltherapy #immunotherapy #TCRt #singlecell #biotech